Skip to main content
Login
User menu
Mega menu
EASL.eu
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Genetic Grand Round
EASL Policy Dialogues
EASL Quiz
ePosters
EASL DeepDive
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - EASL Congress
Industry Symposia - EASL Liver Cancer Summit
Industry Symposia - EASL SLD Summit
GSK Resources
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Patient Resources
This page is dedicated to educational resources for patients with liver disease
Language
English
Year
2020
2022
Displaying results 1 - 12 of 21
Display:
12
24
48
Public Health and Advocacy
EASL Policy Dialogues Episode 2: The liver, alcohol, and politics
EASL Policy Dialogues
View
General Hepatology
EASL Studio S3 E5: JHEP Live: Stigma and alcohol
EASL Studio
View
Viral Hepatitis
EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022
EASL Studio
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN
PDF
View
Public Health and Advocacy
EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - EN
PDF
View
Public Health and Advocacy
EASL Policy Statement on Liver Cancer Screening
PDF
View
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - EN
PDF
View
Public Health and Advocacy
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe
EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance
EASL Policy Dialogues
View
COVID-19 and the liver
Patient Association COVID-19 Toolkit final
PDF
View
COVID-19 and the liver
Care of Patients with Liver Diseases during the COVID-19 Pandemic
Slide Decks
View
General Hepatology
EASL Studio S3 E6: How to improve end-of-life care in liver disease?
EASL Studio
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy